The American College of Physicians has issued an updated guidance statement recommending an HbA1c level between 7% and 8% in most patients with type 2 diabetes. READ MORE
A recent study found a link between HbA1C levels, diabetes status, and long-term cognitive decline.
According to a large prospective real-world study, continuous glucose monitoring provides numerous clinical benefits such as improved glycemic control and quality of life.
Real-World Data Shows Similar Rate of Hypoglycemia Events With Insulin Glargine Injection, Insulin Degludec
Adults with type 2 diabetes who switched from basal insulin therapy to insulin glargine injection experienced similar numbers of hypoglycemia events and decreases in average HbA1c as those who switched to insulin degludec.
Approximately 5.6% of new cancer cases worldwide are attributable to the combined effect of diabetes and a high body mass index.
Research in Review
A biomarker screening pathway for monogenic diabetes is an effective and easy approach to systematically screening young-onset patients.
Continuous subcutaneous insulin infusion is associated with increased hypoglycemia encounters and health care expenditures.
Researchers compared angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers for protecting type 2 diabetes patients.
Bariatric surgery is more effective than standard medical treatment for the long-term control of type 2 diabetes in obese patients.
The American College of Physicians has issued an updated guidance statement recommending an HbA1c level between 7% and 8% in most patients with type 2 diabetes.
According to a recent clinical practice guideline, the management of type 2 diabetes should include shared decision-making, individualized diabetes self-management education, and individualized glycemic management plans.